Skip to content
HowShorted

MEDICAL PROPERTIES TRUST INC short interest in 2022

In 2022, MEDICAL PROPERTIES TRUST INC's disclosed short interest ran from 4.99% of shares outstanding on 14 Jan 2022 to 17.40% on 30 Dec 2022, a change of +12.41 percentage points. The year's high was 17.40% on 30 Dec 2022 and its low 4.77% on 31 Jan 2022, averaging 8.51% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.47 days on 15 Jul 2022. Full history: MEDICAL PROPERTIES TRUST INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MEDICAL PROPERTIES TRUST INC in 2022

2022 in figures

Start of year
4.99% (14 Jan 2022)
End of year
17.40% (30 Dec 2022)
Change
+12.41 pp
High
17.40% (30 Dec 2022)
Low
4.77% (31 Jan 2022)
Average
8.51%
Highest days to cover
8.47 (15 Jul 2022)
SEC filings marked
8

Every report in 2022

MEDICAL PROPERTIES TRUST INC short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20224.99%7.57
31 Jan 20224.77%6.02
15 Feb 20225.24%5.72results (8-K)
28 Feb 20225.09%5.69
15 Mar 20225.10%5.7610-K filed
31 Mar 20225.25%6.21
14 Apr 20225.45%7.46
29 Apr 20226.00%4.99results (8-K)
13 May 20226.33%6.5510-Q filed
31 May 20226.34%7.43
15 Jun 20227.82%4.79
30 Jun 20227.44%4.94
15 Jul 20227.15%8.47
29 Jul 20227.07%8.40
15 Aug 20227.00%5.72results (8-K), 10-Q filed
31 Aug 20228.31%6.10
15 Sep 20229.36%5.66
30 Sep 202211.04%4.03
14 Oct 202212.36%3.42
31 Oct 202212.76%4.19results (8-K)
15 Nov 202213.27%5.9810-Q filed
30 Nov 202213.07%7.83
15 Dec 202215.68%7.36
30 Dec 202217.40%5.79

See also: MEDICAL PROPERTIES TRUST INC's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.